Effective Inhibition of Xenografts of Hepatocellular Carcinoma (HepG2) by Rapamycin and Bevacizumab in an Intrahepatic Model

PURPOSE: Hepatocellular carcinoma (HCC) displays a characteristic hypervascularity and depends on angiogenesis for tumor growth, which thus provides a potential target for therapeutic approaches to HCC. In this study, through the use of combined micro-positron emission tomography (PET)/computed tomo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ong, Lai-Chun, Song, In-Chin, Jin, Yi, Kee, Irene H. C., Siew, Eeyan, Yu, Sidney, Thng, Choon-Hua, Huynh, Hung, Chow, Pierce K. H.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer-Verlag 2009
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719751/
https://ncbi.nlm.nih.gov/pubmed/19330383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-009-0213-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы